"The Viral Load" with Tiffany Hobbs & MORE!!! | KFI AM 640 iheart.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iheart.com Daily Mail and Mail on Sunday newspapers.
Recruitment stopped on the phase 3 trial of the once-daily oral drug islatravir in combination with doravirine, but the study of the investigational new option for HIV continued for the full 48 weeks.
Globally, significant progress has been made, with 86% of people knowing their HIV status. However, new infections persist at a rate that has not dropped as fast as possible.
People living with HIV who are diagnosed and treated early, and take their medication as prescribed, can expect to have the same health and life expectancy as their HIV-negative counterparts.